Skip to main content
Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
4.300
+0.090 (2.14%)
At close: Nov 13, 2026, 4:00 PM EST
4.360
+0.060 (1.40%)
After-hours: Nov 13, 2026, 7:25 PM EST

Atea Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-155.4-158.35-168.39-135.96-115.91121.19
Depreciation & Amortization
0.420.420.420.420.260.03
Loss (Gain) From Sale of Investments
-2.32-4.94-11.82-15.45-5.47-
Stock-Based Compensation
15.1620.7251.7749.4346.7239.62
Other Operating Activities
-6.36-6.36----
Change in Accounts Payable
1.338.490.211.7-1.9810.29
Change in Unearned Revenue
------301.37
Change in Other Net Operating Assets
6.68-7.6814.46-44.643.23
Operating Cash Flow
-140.57-132.03-135.5-85.4-120.98-87.01
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-----1.94-0
Investment in Securities
160.7188.7956.1140.3-453.47-
Investing Cash Flow
160.7188.7956.1140.3-455.41-0

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
1.20.260.270.260.371.47
Repurchase of Common Stock
-0.75-26----
Financing Cash Flow
0.45-25.750.270.260.371.47

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
20.5831.02-79.13-44.84-576.02-85.54

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-140.57-132.03-135.5-85.4-122.93-87.01
Free Cash Flow Growth
------
Free Cash Flow Margin
------24.76%
Free Cash Flow Per Share
-1.77-1.62-1.61-1.02-1.48-0.99
Levered Free Cash Flow
-88.59-71.38-39.55-9.76-69.52-127.65
Unlevered Free Cash Flow
-88.59-71.38-39.55-9.76-69.52-127.65

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
7.9316.48-7.4816.16-46.59-247.85
SEC Filings: 10-K · 10-Q